Deficiency of fibroblast growth factor 21 aggravates obesity-induced atrophic responses in skeletal muscle

Deficiency of fibroblast growth factor 21 aggravates obesity-induced atrophic responses in skeletal muscle

Abstract Background Obesity-induced skeletal muscle inflammation is a major contributor of skeletal muscle loss/atrophy and is implicated in metabolic complications such as insulin resistance. Fibroblast growth factor 21 (FGF21) is known to be an important metabolic regulator with anti-inflammatory...

Full description

Bibliographic Details
Main Authors: Chu-Sook Kim, Yeonsoo Joe, Hye-Seon Choi, Sung Hoon Back, Jeong Woo Park, Hun Taeg Chung, Eun Roh, Min-Seon Kim, Tae Youl Ha, Rina Yu
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Journal of Inflammation
Subjects:
Obesity
Inflammation
Muscle
Atrophy
Fibroblast growth factor 21
Online Access:http://link.springer.com/article/10.1186/s12950-019-0221-3

Internet

http://link.springer.com/article/10.1186/s12950-019-0221-3

Similar Items